











Reproductive rights dominate 2024 ballot measures on health care | STAT


















































































 







Skip to Main Content






















Manage alerts for this article


Email this article


Share this article



























Donald Trump


research


NIH











Newsletters


Log In


My Account


Subscribe Now

 
My Account





Settings
Complete your personal information for a more tailored experience


Billing


Log Out












Reporting from the frontiers of health and medicine




Newsletters


Log In


My Account


Subscribe Now

 

BiotechPharmaPublic HealthHealth TechPolicyScienceFirst OpinionSTAT+STAT Events 


 




















Search



Log In
Try STAT+
My Account



Home





News


Latest


Business


Biotech


Pharma


Health Tech


Health Insurance


Hospitals


Medical Devices




Washington


Policy


FDA


CDC


NIH




Science


CRISPR


Gene Therapy


Research


Neuroscience






Public Health


H5N1 Bird Flu


Addiction


Covid-19


Abortion


Health Disparities


Infectious Disease


Mental Health




Disease


Cancer


Cardiovascular Disease


Chronic Disease


Diabetes


Alzheimer's


Obesity




Features


Coercive Care


The Obesity Revolution


The War on Recovery




 


Newsletters

Opinion
Columns

Adam Feuerstein 
Matthew Herper 
Ed Silverman 



Reports

E-books

Podcasts
Tools & Trackers

CRISPR Tracker 
Breakthrough Device Tracker 
Generative AI Tracker 
Obesity Drug Tracker 





Events

Upcoming Events 
Summits 
2025 Breakthrough East 
2025 Breakthrough West 



Community

STAT Wunderkinds '24 
STAT Madness 


Video

Advertise

STAT Brand Studio 


 Don't miss out Subscribe to STAT+ today, for the best life sciences journalism in the industry

			Learn more		
 








 



Politics

The key ballot measures and races to watch that could reshape health care
 States are voting on abortion access, psychedelics, and long-term care












Manage alerts for this article


Email this article


Share this article




 



Justin Sullivan/Getty Images


 



							By Sarah Owermohle 
Oct. 24, 2024 
							Washington Correspondent						



WASHINGTON — While Vice President Harris and former President Trump are dominating the headlines in the last two weeks before the election, there is a lengthy list of health care proposals and down-ballot races that could heavily shape health policy.  
More than a dozen states are voting on health care issues ranging from abortion access to psychedelics use, paying for long-term care, and medically assisted suicide.advertisement

A handful of those states with ballot initiatives also have key Senate races that could dictate which party controls the chamber and sets the agenda next year. 


STAT+ Exclusive Story
Already have an account? Log in








This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in


Individual plans



Group plans



Monthly
$39
Totals $468 per year
$39/month
Get Started
Totals $468 per year



Starter
$30
for 3 months, then $399/year
$30 for 3 months
Get Started
Then $399/year


Annual
$399
Save 15%
$399/year
Get Started
Save 15%




11+ Users
Custom
Savings start at 25%!
Request A Quote
Request A Quote
Savings start at 25%!



2-10 Users
$300
Annually per user
$300/year
Get Started
$300 Annually per user



View All Plans











						To read the rest of this story subscribe to STAT+.					
Subscribe


Log In






abortion, campaigns, Congress, Election 2024, Pharmaceuticals, Policy, reproductive health, White House



Submit a correction requestReprints

 




 




Sarah Owermohle





Washington Correspondent







Sarah Owermohle reports on the administration’s health care initiatives, federal health policy, and its intersection with politics and the courts. She joined STAT in 2022 after covering health policy at Politico. She is also the co-author of the free, twice-weekly D.C. Diagnosis newsletter.
















Newsletter 
Washington never stops. Cut through the noise with our essential updates on health care politics and policy





Please enter a valid email address.
Sign Up




				Your data will be processed in accordance with our Privacy Policy and Terms of Service. You may opt out of receiving STAT communications at any time.
			


















Recommended
 



 
Exclusive



Exclusive
February 18, 2025 

 
STAT Plus: FDA’s head of device safety among employees terminated in ‘challenging’ weekend					



						By Lizzy Lawrence 








 

The Readout



The Readout
February 18, 2025 

 
						Biogen partners with Stoke Therapeutics to sell severe epilepsy drug					



						By Meghana Keshavan 



advertisement
 




 

The Readout



The Readout
February 14, 2025 

  
STAT Plus: The view from overseas on tumult in U.S. science					



						By Meghana Keshavan 








 

Insurance



Insurance
February 13, 2025 

 
STAT Plus: Judge rules lawsuit over UnitedHealth’s AI care denials can move forward					



						By Bob Herman 








 

The Readout



The Readout
February 13, 2025 

  
STAT Plus: The biotech news stories you need to read today					



						By Meghana Keshavan 







Subscriber Picks
 






STAT Plus:
														Biotech is in a dark place						




							By Adam Feuerstein 









STAT Plus:
														Two biotechs say they're using AI to conjure drugs from scratch. Their documents suggest otherwise 						




							By Brittany Trang 









STAT Plus:
														Trump administration to fire thousands at health agencies						




							By Sarah Owermohle, Lizzy Lawrence, Helen Branswell,  and Matthew Herper 









STAT Plus:
														Second top NIH official, who oversaw awarding of research grants, departs abruptly						




							By Sarah Owermohle and Lev Facher 









STAT Plus:
														Drug inspectors, AI experts, maternal health workers: Trump’s health agency cuts are far-reaching						




							By Helen Branswell 






 










Share options






X





Bluesky





LinkedIn





Facebook





Doximity





Copy link





Reprints














Reporting from the frontiers of health and medicine


Back to top



Company


About


Our Team


Contact Us


Careers


Diversity & Inclusion


Our Awards


Advertise With Us


STAT Brand Studio


Supporters


Licensing Stories


Ethics Policy


AI Policy



Account


STAT+


Group Subscriptions


FAQ


My Account


Log In


Subscribe



More


Events


Newsletters


Reports


App


Podcasts


Community



 




Privacy


Terms


Do Not Sell My Data

©2025 STAT 




















































This from the NYTimes? Wow. How far the mighty have fallen. Sad and weird.